CLOV vs PMCB
Clover Health Investments Corp (CLOV) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
CLOV currently screens at market cap $1.55B. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the CLOV and PMCB stock pages for the full models.
Not investment advice.